TXMD
TherapeuticsMD, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$2.19
+0.46%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 12.82x
- P/E 2027E
- 11.47x
- P/E 2028E
- —
- P/S forward
- 0.26x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.93x
- Price / sales
- 7.75x
- Price / cash flow
- 8.12x
Enterprise value
- Enterprise value
- $21.7M
- EV / sales
- 6.64x
- EV / EBITDA
- -5.18x
- EV / EBIT
- -5.64x
- Market cap
- $25.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026